These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 825469)

  • 1. Mycobacterial ribonucleic acid: comparison with mycobacterial cell wall fractions for regression of murine tumor growth.
    Millman I; Scott AW; Halbherr T; Youmans AS; Youmans GP
    Infect Immun; 1976 Oct; 14(4):929-33. PubMed ID: 825469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I; Scott AW; Halbherr T
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
    Taniyama T; Azuma I; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterial RNA. A comparison with intact mycobacteria for suppression of murine tumor growth.
    Millman I; Maguire HC; Pass M; Youmans AS; Youmans GP
    J Med; 1976; 7(3-4):249-61. PubMed ID: 827594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.
    Neiburger RG; Youmans GP; Youmans AS
    Infect Immun; 1973 Jul; 8(1):42-7. PubMed ID: 4198103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the H37Ra strain of M. tuberculosis and of a mycobacterial RNA fraction on tumor growth.
    Millman I; Maguire HC; Youmans GP; Youmans AS
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):765-8. PubMed ID: 4216902
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of tumor growth and regression of established tumor with oil-attached mycobacterial fractions.
    Yamamura Y; Azuma I; Taniyama T; Ribi E; Zbar B
    Gan; 1974 Apr; 65(2):179-81. PubMed ID: 4209836
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metabolic inhibitors on the formation of antibody to sheep erythrocytes, on development of delayed hypersensitivity, and on the immune response to infection with Mycobacterium tuberculosis in mice.
    Youmans AS; Youmans GP
    Infect Immun; 1978 Jan; 19(1):212-6. PubMed ID: 415003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions.
    Coppel S; Youmans GP
    J Bacteriol; 1969 Jan; 97(1):114-20. PubMed ID: 4974383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical analyses and antitumor activity of hydrosoluble substances from Mycobacterium bovis, strain BCG.
    Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1983 May; 140(1):35-43. PubMed ID: 6191409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of three mycobacterial ribosomal fractions.
    Portelance V; Beaudet R
    Can J Microbiol; 1983 Feb; 29(2):185-93. PubMed ID: 6189570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of peritoneal macrophages in cellular responses to mastocytoma in resistant and susceptible mice.
    Farber P; Specter S; Friedman H
    Adv Exp Med Biol; 1979; 121B():521-30. PubMed ID: 121034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.
    Youmans AS; Youmans GP
    J Bacteriol; 1966 Jun; 91(6):2146-54. PubMed ID: 4957610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiological studies with mycobacterial ribonucleic acid-protein complex: Part I--Immune responses and protective role against experimental tuberculosis.
    Pancholi P; Vinayak VK; Khuller GK
    Indian J Exp Biol; 1990 Feb; 28(2):119-26. PubMed ID: 1695195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of ribonucleic acid-protein fraction of Mycobacterium tuberculosis encapsulated in liposomes.
    Pancholi P; Vinayak VK; Khuller GK
    J Med Microbiol; 1989 Jun; 29(2):131-8. PubMed ID: 2471834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soluble immune complexes by their binding to Fc receptors on mastocytoma cells.
    Targowski SP; Milgrom F
    Cell Immunol; 1980 Sep; 54(2):478-86. PubMed ID: 6774817
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of protection afforded by ribonucleic acid preparations from Mycobacterium tuberculosis against Mycobacterium leprae infections in mice.
    Shepard CC; Youmans AY; Youmans GP
    Infect Immun; 1977 Mar; 15(3):733-6. PubMed ID: 404242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse.
    Bertschmann M; Schären B; Lüscher EF
    Immunobiology; 1980 Jan; 156(4-5):382-99. PubMed ID: 6768671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.